Ipsen Sa ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPSEY | NBIX | MDGL | ||
| Company | Ipsen Sa ADR | Neurocrine Bioscienc | Madrigal Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 44.8100 | 176.46 | 555.00 | ||
| High | 44.8100 | 179.15 | 566.18 | ||
| Low | 44.8100 | 176.00 | 548.68 | ||
| Latest | 44.8100 | 176.41 | 551.25 | ||
| Change | -2.3000 | +0.64 | +6.74 | ||
| % Change | -4.88% | +0.36% | +1.24% | ||
| Volume | 200 | 1,047,900 | 268,600 | ||
| 20-Day Average Volume | 1,545 | 1,101,780 | 297,495 | ||
| Previous Close | 47.1100 | 175.77 | 544.51 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 45.8205 | 173.99 | 541.00 | ||
| 20-Day Raw Stochastic | 28.93% | 68.76% | 71.33% | ||
| 20-Day Relative Strength | 47.71 | 59.78 | 56.52 | ||
| Weighted Alpha | +32.42 | +42.20 | +64.88 | ||
| Today's Opinion | 40% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 72% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.65% since 07/09/26 | +1.97% since 07/20/26 | +2.90% since 07/20/26 | ||
| Low | 44.0700 on 07/14/26 | 170.00 on 07/23/26 | 526.60 on 07/23/26 | ||
| High | 47.7200 on 07/10/26 | 181.00 on 07/22/26 | 566.18 on 07/27/26 | ||
| 1-Month | |||||
| %Chg | -3.63% since 06/23/26 | +4.68% since 06/26/26 | +7.53% since 06/26/26 | ||
| Low | 44.0700 on 07/14/26 | 165.91 on 07/01/26 | 506.00 on 06/29/26 | ||
| High | 48.7600 on 07/09/26 | 181.18 on 07/10/26 | 569.44 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | -6.66% since 04/23/26 | +37.78% since 04/27/26 | +5.99% since 04/27/26 | ||
| Low | 43.2022 on 06/02/26 | 126.49 on 04/29/26 | 445.20 on 06/03/26 | ||
| High | 51.1000 on 05/05/26 | 181.18 on 07/10/26 | 569.44 on 07/09/26 | ||
| 6-Month | |||||
| %Chg | +10.40% since 01/23/26 | +31.76% since 01/27/26 | +10.16% since 01/27/26 | ||
| Low | 39.6900 on 02/05/26 | 122.14 on 02/12/26 | 416.21 on 03/03/26 | ||
| High | 51.1000 on 05/05/26 | 181.18 on 07/10/26 | 572.20 on 03/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,022,911 | 17,673,676 | 12,554,218 | ||
| Shares Outstanding, K | 335,258 | 100,550 | 23,056 | ||
| Annual Sales | 4,445,500,000 | 2,860,500,000 | 958,400,000 | ||
| Annual Net Income | 501,780,000 | 478,600,000 | -288,280,000 | ||
| Last Quarter Sales | N/A | 814,500,000 | 311,340,000 | ||
| Last Quarter Net Income | N/A | 197,900,000 | -94,390,000 | ||
| 60-Month Beta | 0.41 | 0.39 | -1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.94 on 05/05/26 | -3.25 on 05/06/26 | ||
| Earnings Date | 02/12/26 | 07/30/26 | 07/30/26 | ||
| Most Recent Dividend | 0.300 on 06/04/26 | N/A | N/A | ||
| Next Ex-Dividends Date | 06/04/26 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.32 | 0.00 | ||